Meckler Jeffrey A

CIK 00015069166 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001506916

Recent Transactions

50 trades

Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-05-19+12,000→ 12,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-19+4,000→ 91,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-04$45.00/sh−8,000→ 87,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-05-04−8,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-04$16.33/sh+8,000→ 95,500 total
Award
Indaptus Therapeutics, Inc.$INDP
Warrants (right to buy)
2026-02-11+1,519→ 1,519 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Warrants (right to buy)
2026-02-11−3,033→ 0 total
Award
Indaptus Therapeutics, Inc.$INDP
Warrants (right to buy)
2026-02-11+12,136→ 12,136 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Warrants (right to buy)
2026-02-11−12,136→ 0 total
Award
Indaptus Therapeutics, Inc.$INDP
Warrants (right to buy)
2026-02-11+3,033→ 3,033 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Warrants (right to buy)
2026-02-11−1,519→ 0 total
Award
Indaptus Therapeutics, Inc.$INDP
Common Stock
2025-07-27$8.30/sh+6,068→ 13,312 total
Award
Indaptus Therapeutics, Inc.$INDP
Common Stock Warrants
2025-07-27$8.30/sh+12,136→ 16,688 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2025-05-15+19,500→ 19,500 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-15+6,500→ 87,500 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.04/sh−813→ 0 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.04/sh−1,563→ 0 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.04/sh−3,750→ 0 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.04/sh−4,750→ 0 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2025-04-10$0.04/sh−1,250→ 0 total
Disposition to Issuer
Indaptus Therapeutics, Inc.$INDP
sStock Option (right to buy)
2025-04-10$0.04/sh−1,500→ 0 total
Award
Indaptus Therapeutics, Inc.$INDP
Common Stock Warrants
2024-11-25$1.18/sh+42,553→ 42,553 total
Award
Indaptus Therapeutics, Inc.$INDP
Common stock
2024-11-25$1.18/sh+42,553→ 202,859 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (Right to Buy)
2024-10-09+75,000→ 75,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-30$10.48/sh+40,000→ 121,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2024-09-30+40,000→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-30$14.06/sh−40,000→ 81,000 total
Award
Indaptus Therapeutics, Inc.$INDP
Common Stock Warrants
2024-08-08$1.82/sh+84,932→ 84,932 total
Award
Indaptus Therapeutics, Inc.$INDP
Common stock
2024-08-08$1.82/sh+84,932→ 160,306 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-05-08+6,500→ 81,000 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2024-05-08+19,500→ 19,500 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (Right to Buy)
2024-01-22+100,000→ 100,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-05-17+4,500→ 74,500 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2023-05-17+13,500→ 13,500 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (Right to Buy)
2023-01-18+100,000→ 100,000 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common stock
2022-11-21$1.90/sh+9,600→ 75,374 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common stock
2022-11-18$1.76/sh+400→ 65,774 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common stock
2022-09-08$2.80/sh+10,308→ 65,374 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common stock
2022-09-07$2.57/sh+8,632→ 55,066 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common stock
2022-09-06$2.44/sh+1,060→ 46,434 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common stock
2022-06-06$2.63/sh+19,727→ 45,374 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-05-11+3,000→ 70,000 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2022-05-11+9,000→ 9,000 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2022-01-26+200,000→ 200,000 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common Stock
2021-11-18$5.82/sh+11,187→ 25,647 total
Purchase
Indaptus Therapeutics, Inc.$INDP
Common Stock
2021-09-14$7.00/sh+12,000→ 14,460 total
Award
Indaptus Therapeutics, Inc.$INDP
Stock Option (right to buy)
2021-08-04+375,000→ 375,000 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2021-05-14+9,000→ 9,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-05-14+3,000→ 67,000 total
Award
Intec Pharma Ltd.
Stock Option (right to buy)
2020-07-15+300,000→ 300,000 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov